# Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation

> **NCT01332747** · PHASE2 · COMPLETED · sponsor: **Jamia Hamdard University** · enrollment: 128 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** safoof e muhazzil
- **DRUG:** compressed tablet of safoof e muhazzil
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT01332747
- **Lead sponsor:** Jamia Hamdard University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2014-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01332747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01332747, "Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01332747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*